Selected Grants
Benefit Risk Tradeoffs Associated with PRO for PAD - Option Period
ResearchCo Investigator · Awarded by Food and Drug Administration · 2022 - 2024PASSION CVR Think Tank
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by Boston Scientific Corporation · 2024 - 2024CSRC Prevention of Sudden Cardiac Death in the Young: National Cardiac Screening Warehouse Pilot Study
ResearchProgram Director · Awarded by Food and Drug Administration · 2019 - 2022Benefit Risk Tradeoffs Associated with PRO for PAD
ResearchCo Investigator · Awarded by Food and Drug Administration · 2020 - 2022Biosensors Registry for BioFreedom Drug Coated Stent (DCS) - LOI
Clinical TrialPrincipal Investigator · Awarded by Biosensors Research USA, Inc. · 2016 - 2021Core variable Assessment Towards a NatIonal evaluation Program (CATNIP) - Subcontract with Weill Cornell
ResearchCo Investigator · Awarded by Weill Cornell Medicine · 2020 - 2021MDEpiNet J&J Dues
ResearchPrincipal Investigator · Awarded by Johnson & Johnson · 2020 - 2020MDEpinNet: RAPID Phase II
ResearchPrincipal Investigator · Awarded by W. L. Gore & Associates, Inc. · 2019 - 2019MEDpiNET: Industry Funding
ResearchPrincipal Investigator · Awarded by Johnson & Johnson · 2017 - 2017Advancing Medical Device Postmarket Surveillance Infrastructure and Epidemiologic Methodologies through Multi-stakeholder Partnership (U01)
ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 2013 - 2017Retrospective QTc Analysis for PER977-01-001
ResearchPrincipal Investigator · Awarded by Perosphere, Inc. · 2014 - 2015Hostility & Coronary Risk: Role Of Weak Vagal Function
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1991 - 1995External Relationships
- Abbott Vascular
- Abiomed, Inc. (now acquired by Johnson & Johnson)
- Angelmed, Inc.
- Diaxamed
- Getinge
- Infraredx (now owned by Nipro, Japan)
- OrbusNeich
- SMT
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.